Microtest Matrices has developed a novel, proprietary technology platform to allow fully-automated, reliable and inexpensive in vitro diagnostic multiplex tests.

MtM’s first system, about to receive CE marking and ready for worldwide commercialisation, provides full allergy profiles.

MtM is also developing multiplex test for autoimmune, infectious diseases and influenza diagnosis.